Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

CASGEVY is the first, and only, gene editing therapy approved for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD) in Europe -- Italy has the largest ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Finance is fast becoming one of the most high-impact areas for AI adoption. From anomaly detection to predictive compliance, today’s AI-powered tools help turn complexity into easily digestible data ...

We'll compare five of the best IDP platforms available in 2025, covering what they do well, where they may fall short, and ...

An investigational extended-release formulation of minoxidil appears to result in more hair growth in a small phase 2 trial comparing it with immediate-release oral and topical formulations.

Cerebras’s hosted Qwen3 Coder service promised to be the Claude replacement many developers craved. We’re losing hope.

For CTOs and senior technology leaders, cloud cost optimization is no longer a back-office exercise—it’s a boardroom priority ...

AI shifts from promise to practice when customization becomes routine. That is a positive sign. When technical teams work with data as it is, measure progress with discipline, and focus on workflows ...